Intimation of Schedule of Analyst / Institutional Investor Meetings
Pfizer Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".08-12-2016
08-12-2016
Pfizer fined $106 mn for 'unfair' prices of epilepsy drug
Flynn Pharma fined $6.55 million; CMA also ordered the companies to reduce their prices07-12-2016
Pfizer to relaunch Corex in new formulation
Pfizer will be launching a series of products as line extensions under the Corex brand name, starting with the first launch in December 201629-11-2016
Updates
Pfizer Ltd has informed BSE that the Company has undertaken a comprehensive review of its respiratory offerings in order to better cover a broader range of indications through an expanded product portfolio. As a result of this review, the Company will launch additional products while it may also discontinue the manufacture of certain SKUs where needed....29-11-2016
Pfizer offers low-cost pneumonia shot
US pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to NGOs seeking to protect vulnerable people from illness in humanitarian crises. In what it...11-11-2016
Transcript of the tele conference call with the Analysts
Pfizer Ltd has submitted to BSE a copy of "Transcript of the tele conference call with the Analysts".08-11-2016
Pfizer Q2 profit up 52% at Rs126 crore
Pfizer net sales rose to Rs552.08 crore for the July- September quarter, compared with Rs525.04 crore during the same period of previous fiscal04-11-2016
Appointment of Additional Director (Woman Director)
Pfizer Ltd has informed BSE that the Board of Directors of the Company has appointed Dr. Anurita Majumdar as an Additional Director (Woman Director) of the Company, designated as Executive Director, Medical with effect from November 04, 2016 for a period of 5 years. The appointment of Dr. Anurita Majumdar will be subject to the approval of shareholders at the ensuing Annual General Meeting of the Company.04-11-2016
Updates
Pfizer Ltd has informed BSE that a teleconference call has been scheduled with the analysts on November 07, 2016, at 4.30 p.m. to discuss the Companys financial performance for the second quarter and half year ended September 30, 2016.04-11-2016
Resignation of Non-executive (Woman) Director
Pfizer Ltd has informed BSE that Ms. Lu Hong has resigned as the Non-executive (Woman) Director from the Board of the Company effective November 04, 2016, on account of her relocation to USA for taking up a global role with Pfizer Inc., USA.04-11-2016